Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts
Miguel Martín(Hospital General Universitario Gregorio Marañón), Sara López‐Tarruella(Hospital General Universitario Gregorio Marañón)
Cited by 30
Related Papers
Molecular predictors of efficacy of adjuvant weekly paclitaxel in early breast cancer
|Breast Cancer Research and Treatment|2009|82
<i>CCNE1</i> and <i>PLK1</i> Mediate Resistance to Palbociclib in HR+/HER2− Metastatic Breast Cancer
|Clinical Cancer Research|2023|54